CD19 and neoplasm: Univariate survival analysis demonstrated that deeper tumor infiltration, increased lymph node involvement, metastasis, higher tumor stage, low IPD-L1 expression, and low levels of CD8 or CD19 expression were high-risk factors for OS (Table 3).